Biological Markers in Psychiatry and Neurology. Proceedings of a Conference Held at the Ochsner Clinic, New Orleans, on May 8–10, 1981

Content: 
Other Pergamon publications of relevant interest, Page ii
Front Matter, Page iii
Copyright, Page iv
FOREWORD, Pages v-vi, Earl Usdin, Israel Hanin
LIST OF PARTICIPANTS, Pages xi-xiv
ABBREVIATIONS, Pages xv-xvi
HIGH RISK STUDIES IN AFFECTIVE DISORDERS, Pages 3-11, D.L. Dunner
BIOLOGICAL MARKERS OF SEPARATION INDUCED DEPRESSION IN PRIMATE MODELS, Pages 13-22, W.T. McKinney, E.C. Moran, G.W. Kraemer
BIOCHEMICAL DISCRIMINATION OF SUBGROUPS OF DEPRESSIVE DISORDERS BASED ON DIFFERENCES IN CATECHOLAMINE METABOLISM, Pages 23-33, J.J. Schildkraut, P.J. Orsulak, A.F. Schatzberg, J.O. Cole, A.H. Rosenbaum
CLINICAL STUDIES OF THE GABA SYSTEM IN PSYCHIATRIC DISORDERS, Pages 35-38, M.B. Bowers Jr., B.I. Gold, R.H. Roth
SEROTONIN UPTAKE IN BLOOD PLATELETS AS A BIOLOGICAL MARKER FOR MAJOR DEPRESSIVE DISORDERS, Pages 39-48, H.Y. Meltzer, R.C. Arora, P. Song
A CROSS-CULTURAL DESIGN TO TEST A BIOLOGICAL HYPOTHESIS OF SCHIZOPHRENIA, Pages 49-59, S.G. Potkin, D.V. Jeste, F. Karoum, D.R. Doongaji, J.S. Apte, A.S. Sheth, L.-W. Chuang, R.J. Wyatt
HUMAN PLASMA MELATONIN: A MARKER FOR ADRENERGIC FUNCTION, CIRCADIAN RHYTHMS, AND RESPONSIVITY TO ENVIRONMENTAL LIGHT, Pages 61-65, A.J. Lewy
POSTMORTEM NEUROCHEMICAL STUDIES IN CHRONIC SCHIZOPHRENIA, Pages 67-76, J.E. Kleinman, F. Karoum, J.E. Rosenblatt, J.C. Gillin, J. Hong, T.P. Bridge, S. Zalcman, F. Storch, R. del Carmen, R.J. Wyatt
MONOAMINE OXIDASE AND SCHIZOPHRENIA, Pages 79-96, L.E. DeLisi, C.D. Wise, T.P. Bridge, B.H. Phelps, S.G. Potkin, R.J. Wyatt
THE RELATIONSHIP OF PLATELET MAO ACTIVITY TO PSYCHOLOGICAL VARIABLES UNDERLYING PSYCHIATRIC DIAGNOSES, Pages 97-109, R. Coursey, M.S. Buchsbaum
MOLECULAR PROPERTIES OF PLATELET MAO IN PSYCHIATRIC PATIENTS AND CONTROLS, Pages 111-121, E. Giller, C. Castiglione, J. Wojciechowski, X.O. Breakefield
PLATELET MONOAMINE OXIDASE AS A BIOLOGICAL MARKER IN THE AFFECTIVE DISORDERS AND ALCOHOLISM, Pages 123-134, D.L. Murphy, R.D. Coursey, T. Haenel, J. Aloi, M.S. Buchsbaum
MEMBRANE TRANSPORT PROCESSES IN AFFECTIVE ILLNESS, Pages 137-151, A.G. Mallinger, I. Hanin
SODIUM DEPENDENT MEMBRANE PROCESSES IN MAJOR AFFECTIVE DISORDERS, Pages 153-168, D.G. Ostrow, M. Trevisan, A. Okonek, R. Gibbons, R. Cooper, J.M. Davis
LITHIUM RATIO, LITHIUM RESPONSE AND THE SCHIZOPHRENIAS, Pages 169-175, D. Garver, R.J. Hitzemann, J. Hirschowitz
ABNORMALITIES IN MEMBRANE LIPIDS ASSOCIATED WITH DEFICIENCIES IN LITHIUM COUNTERFLOW, Pages 177-182, R.J. Hitzemann, D.L. Garver
PHOSPHOLIPIDS AS MARKERS FOR SCHIZOPHRENIA, Pages 183-186, F.A. Henn, S.W. Henn
RED BLOOD CELL CHOLINE AS A POTENTIAL MARKER IN PSYCHIATRIC AND NEUROLOGIC DISEASE, Pages 187-190, I. Hanin
[3H] IMIPRAMINE BINDING TO THE SEROTONIN “TRANSPORTER” IN HUMAN BRAIN AND PLATELET: A POSSIBLE BIOLOGICAL MARKER IN DEPRESSION, Pages 193-204, S.M. Paul, M. Rehavi, P. Skolnick, F.K. Goodwin
α2-ADRENERGIC RECEPTORS: COMPARATIVE BIOCHEMISTRY OF NEURAL AND NON-NEURAL RECEPTORS, AND IN VITRO ANALYSIS IN PSYCHIATRIC PATIENTS, Pages 205-217, D.C. U'Prichard, M. Daiguji, C. Tong, J.C. Mitrius, H.Y. Meltzer
BRAIN DOPAMINE RECEPTORS IN SCHIZOPHRENIA, Pages 219-226, T. Lee, P. Seeman
THE DEXAMETHASONE SUPPRESSION TEST: AN ESTABLISHED BIOLOGICAL MARKER OF MELANCHOLIA, Pages 229-240, J.F. Greden
EEG STUDIES OF SLEEP AND THE DEXAMETHASONE SUPPRESSION TEST IN THE DIAGNOSIS OF DEPRESSION, Pages 241-251, M. Feinberg
PHYSOSTIGMINE RESPONSES AS MARKERS IN AFFECTIVE DISORDER PATIENTS, Pages 253-259, D. Janowsky, C. Risch, L. Judd, D. Parker, L. Huey
HYPOTHALAMIC-PITUITARY-ADRENAL AXIS ACTIVITY: THE IMPORTANCE OF DELUSIONS AND FAMILIAL SUBTYPING, Pages 261-267, W. Coryell, G. Gaffney, P.E. Burkhardt, G. Winokur
CHOLINERGIC-ß-ENDORPHIN HYPERSENSITIVITY ASSOCIATED WITH DEPRESSION, Pages 269-278, S.C. Risch, D.S. Janowsky, N.H. Kalin, R.M. Cohen, J.A. Aloi, D.L. Murphy
THE TRH-INDUCED TSH RESPONSE: A POSSIBLE NEUROENDOCRINE MARKER, Pages 279-290, P.T. Loosen, A.J. Prange Jr.
THE TRH TEST IN DEPRESSIVE AND MANIC-DEPRESSIVE ILLNESS, Pages 291-298, I. Extein, A.L.C. Pottash, M.S. Gold
MIF-1 AND REGULATION OF THE HYPOTHALAMIC-PITUITARY-ADRENOCORTICAL SYSTEM IN DEPRESSION, Pages 299-305, R.H. Ehrensing, A.J. Kastin
GROWTH HORMONE AND LITHIUM RATIOS PREDICT SUCCESS OF LITHIUM IN THE SCHIZOPHRENIAS, Pages 307-316, J. Hirschowitz, F. Zemlan, D. Garver
HUMAN IMMUNOREACTIVE MELATONIN AND CORTISOL DURING ACUTE STRESS AND COMPARISON OF THEIR RHYTHMS, Pages 317-330, G. Vaughan, S. Harris, J. Allen, C. Delea
BLINKING AS AN ATTENTIONAL VARIABLE IN SCHIZOPHRENIA, Pages 333-337, R. Cancro, P. Van Gelder
BLINK RATES IN SCHIZOPHRENIA, Pages 339-345, C.N. Karson, J.E. Kleinman, W.J. Freed, L.B. Bigelow, D.R. Weinberger, R.J. Wyatt
AUTONOMIC NERVOUS SYSTEM MARKERS OF DIAGNOSIS AND PROGNOSIS IN SCHIZOPHRENIA, Pages 347-358, T.P. Zahn
PSYCHOLOGICAL AND PHYSIOLOGICAL CORRELATES OF VARIATIONS IN SMOOTH PURSUIT EYE MOVEMENTS, Pages 359-370, L.J. Siever, R.D. Coursey, I.S. Alterman, M.S. Buchsbaum, D.L. Murphy
VULNERABILITY TO SCHIZOPHRENIA: INFORMATION PROCESSING IN THE PUPIL AND EVENT-RELATED POTENTIAL, Pages 371-385, S. Steinhauer, J. Zubin
EEG SLEEP AS BIOLOGICAL MARKERS IN DEPRESSION, Pages 387-396, David J. Kupfer
CHOLINERGIC REM SLEEP INDUCTION—A TRAIT MARKER OF AFFECTIVE ILLNESS?, Pages 397-404, Natraj Sitaram, W.H. Kaye, J.I. Numberger, M. Ebert, E.S. Gershon, J.C. Gillin
ANOMALIES OF NEURO-SENSORY FUNCTIONS AND REPRESENTATIONAL WORLD IN SCHIZOPHRENICS, Pages 405-421, G. Werner, F.O. Black, C. Cornes, A. Larkin, S. Steinhauer
TOWARD A BIOCHEMICAL DEFINITION OF ALCOHOLISM, Pages 425-432, R.S. Ryback, M.J. Eckardt
THE GENETICS OF ALCOHOLISM, Pages 433-443, D.W. Goodwin
A PROSPECTIVE STUDY OF GENETIC MARKERS IN ALCOHOLISM, Pages 445-455, M.A. Schuckit
GENETIC LINKAGE MARKERS IN THE STUDY OF PSYCHIATRIC DISORDERS, Pages 459-466, K.K. Kidd
GENETIC HETEROGENEITY OF HUMAN BRAIN PROTEINS AND THEIR DIAGNOSIS IN LIVING PATIENTS, Pages 467-472, D.E. Comings
INBORN ERRORS, INBORN PREDISPOSITIONS, AND NORMAL VARIATION: SOME IMPLICATIONS FOR PSYCHIATRIC RESEARCH, Pages 473-482, J.P. Blass
HLA AND REVERSED CEREBRAL ASYMMETRIES: POSSIBLE MARKERS FOR A SUBGROUP OF SCHIZOPHRENICS, Pages 485-493, D.J. Luchins, D.R. Weinberger, E.F. Torrey, R.J. Wyatt
TOPOGRAPHIC ANALYSIS OF COMPUTER PROCESSED ELECTROENCEPHALOGRAPHY IN SCHIZOPHRENIA, Pages 495-504, J.M. Morihisa, F.H. Duffy, R.J. Wyatt
CEREBRAL VENTRICULAR SIZE: A BIOLOGICAL MARKER FOR SUBTYPING CHRONIC SCHIZOPHRENIA, Pages 505-512, D.R. Weinberger, R.J. Wyatt
MECHANISM, MATHEMATICS AND MARKERS OF MENTAL DISEASE, Pages 515-523, J.M. Davis, R.D. Gibbons, G.N. Pandey, J.I. Javaid
STOCHASTIC MARKERS FOR AN ENTROPIC DEFECT IN THE SCHIZOPHRENIC SYNDROME: A VERTICAL INTEGRATION, Pages 525-535, Arnold J. Mandell
GENERAL DISCUSSIONS, Pages 539-541
SUMMARY OF THE CONFERENCE ON BIOLOGICAL MARKERS IN PSYCHIATRY AND NEUROLOGY ON COURAGEOUS LIONS, MOTHER-ENZYME INTERACTIONS, AND PSYCHOPATHOLOGICAL STYLE, Pages 543-546, A.J. Mandell
SUBJECT INDEX, Pages 547-548